Genmab A/S GNMSF Company Overview
Stock Message Board http://investorshangout.com/search?q=GNMSF&am...mp;yt1=Go!
Last Updated: Sunday, October 13, 2013 04:46:41 AM
Genmab A/S GNMSF Current Price and Quotes
Last Price 41.60
Previous Close 41.60 Open N/A
Daily Range N/A - N/A 52wk Range 42.80 - 12.00
Volume 0 Dividend N/A
Average Vol (3m) 5,161 Yield N/A
Genmab A/S GNMSF
Company Information
Bredgade 34E
Copenhagen K DK-1260
Denmark
Website: http://www.genmab.com
Phone: 45-70-20-27-28
Genmab A/S GNMSF
Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Genmab A/S GNMSF
Financial Reportings and Disclosures
Reporting Status International Reporting: OMX Nordic Exchange Copenhagen
CIK 0001434265
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification
Incorporated In: Denmark
Year of Inc. 1999
Employees 179 a/o Sep 30, 2012
Company Officers/Contacts
Jan G. J. van de Winkel President, CEO
David A. Eatwell CFO
Rachel Curtis Gravesen SVP, Inv. Rel.
Company Directors
Not Available
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Genmab A/S GNMSF
GNMSF Security Details Other Company Securities
Share Structure
Market Value1 $1,868,137,024 a/o Oct 11, 2013
Shares Outstanding 44,907,140 a/o Dec 22, 2011
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
GEN - OMX Nordic Exchange Copenhagen - Qualified
Short Selling Data
Short Interest 77,671 (73.59%)
Sep 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Genmab A/S GNMSF Financials
Data is unavailable at this time. Please check this page later.
Genmab A/S GNMSF Recent News
Oct 10, 2013 Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis
Oct 4, 2013 GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Sept 14, 2013 FDA Grants GSK and Genmab's Arzerra(R) (Ofatumumab) Breakthrough Therapy Designation for Previously Untreated Chronic Lymphocytic Leukemia
Sept 10, 2013 Genmab Announces New Study of Daratumumab in Double Refractory Multiple Myeloma
Aug 26, 2013 Genmab Reaches Milestone in DuoBody Platform Collaboration With Janssen
Aug 14, 2013 Genmab Announces Financial Results for the First Half of 2013 and Improves 2013 Financial Guidance
Jul 24, 2013 Arzerra(R) Second Quarter 2013 Net Sales Figures
Jul 18, 2013 Genmab Files IND for HuMax-TF-ADC
Jul 16, 2013 Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
GNMSF Genmab A/S Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GNMSF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GNMSF/quote
Stock Chart http://www.otcmarkets.com/stock/GNMSF/chart
Company Info http://www.otcmarkets.com/stock/GNMSF/company-info
Recent News http://www.otcmarkets.com/stock/GNMSF/news
Financials http://www.otcmarkets.com/stock/GNMSF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GNMSF/filings
Short Sales http://www.otcmarkets.com/stock/GNMSF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GNMSF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GNMSF/research
Summary http://finance.yahoo.com/q?s=GNMSF
Historical Prices http://finance.yahoo.com/q/hp?s=GNMSF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GNMSF
Basic Chart http://finance.yahoo.com/q/bc?s=GNMSF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GNMSF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GNMSF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GNMSF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GNMSF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GNMSF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GNMSF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GNMSF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GNMSF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GNMSF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GNMSF
Balance Sheet http://finance.yahoo.com/q/bs?s=GNMSF
Cash Flow http://finance.yahoo.com/q/cf?s=GNMSF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GNMSF
Market Watch http://www.marketwatch.com/investing/stock/GNMSF
Bloomberg http://www.bloomberg.com/quote/GNMSF:US
Morningstar http://quotes.morningstar.com/stock/s?t=GNMSF
Bussinessweek http://investing.businessweek.com/research/st...cker=GNMSF
Barchart http://www.barchart.com/quotes/stocks/GNMSF
OTC Short Report http://otcshortreport.com/index.php?index=GNMSF
Investopedia http://www.investopedia.com/markets/stocks/GNMSF/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Stock Message Board http://investorshangout.com/search?q=GNMSF&am...mp;yt1=Go!
Last Updated: Sunday, October 13, 2013 04:46:41 AM
Genmab A/S GNMSF Current Price and Quotes
Last Price 41.60
Previous Close 41.60 Open N/A
Daily Range N/A - N/A 52wk Range 42.80 - 12.00
Volume 0 Dividend N/A
Average Vol (3m) 5,161 Yield N/A
Genmab A/S GNMSF
Company Information
Bredgade 34E
Copenhagen K DK-1260
Denmark
Website: http://www.genmab.com
Phone: 45-70-20-27-28
Genmab A/S GNMSF
Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Genmab A/S GNMSF
Financial Reportings and Disclosures
Reporting Status International Reporting: OMX Nordic Exchange Copenhagen
CIK 0001434265
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification
Incorporated In: Denmark
Year of Inc. 1999
Employees 179 a/o Sep 30, 2012
Company Officers/Contacts
Jan G. J. van de Winkel President, CEO
David A. Eatwell CFO
Rachel Curtis Gravesen SVP, Inv. Rel.
Company Directors
Not Available
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Genmab A/S GNMSF
GNMSF Security Details Other Company Securities
Share Structure
Market Value1 $1,868,137,024 a/o Oct 11, 2013
Shares Outstanding 44,907,140 a/o Dec 22, 2011
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
GEN - OMX Nordic Exchange Copenhagen - Qualified
Short Selling Data
Short Interest 77,671 (73.59%)
Sep 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Genmab A/S GNMSF Financials
Data is unavailable at this time. Please check this page later.
Genmab A/S GNMSF Recent News
Oct 10, 2013 Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis
Oct 4, 2013 GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Sept 14, 2013 FDA Grants GSK and Genmab's Arzerra(R) (Ofatumumab) Breakthrough Therapy Designation for Previously Untreated Chronic Lymphocytic Leukemia
Sept 10, 2013 Genmab Announces New Study of Daratumumab in Double Refractory Multiple Myeloma
Aug 26, 2013 Genmab Reaches Milestone in DuoBody Platform Collaboration With Janssen
Aug 14, 2013 Genmab Announces Financial Results for the First Half of 2013 and Improves 2013 Financial Guidance
Jul 24, 2013 Arzerra(R) Second Quarter 2013 Net Sales Figures
Jul 18, 2013 Genmab Files IND for HuMax-TF-ADC
Jul 16, 2013 Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
GNMSF Genmab A/S Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GNMSF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GNMSF/quote
Stock Chart http://www.otcmarkets.com/stock/GNMSF/chart
Company Info http://www.otcmarkets.com/stock/GNMSF/company-info
Recent News http://www.otcmarkets.com/stock/GNMSF/news
Financials http://www.otcmarkets.com/stock/GNMSF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GNMSF/filings
Short Sales http://www.otcmarkets.com/stock/GNMSF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GNMSF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GNMSF/research
Summary http://finance.yahoo.com/q?s=GNMSF
Historical Prices http://finance.yahoo.com/q/hp?s=GNMSF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GNMSF
Basic Chart http://finance.yahoo.com/q/bc?s=GNMSF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GNMSF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GNMSF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GNMSF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GNMSF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GNMSF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GNMSF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GNMSF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GNMSF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GNMSF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GNMSF
Balance Sheet http://finance.yahoo.com/q/bs?s=GNMSF
Cash Flow http://finance.yahoo.com/q/cf?s=GNMSF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GNMSF
Market Watch http://www.marketwatch.com/investing/stock/GNMSF
Bloomberg http://www.bloomberg.com/quote/GNMSF:US
Morningstar http://quotes.morningstar.com/stock/s?t=GNMSF
Bussinessweek http://investing.businessweek.com/research/st...cker=GNMSF
Barchart http://www.barchart.com/quotes/stocks/GNMSF
OTC Short Report http://otcshortreport.com/index.php?index=GNMSF
Investopedia http://www.investopedia.com/markets/stocks/GNMSF/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
